WHO ICTRP trial
Multicenter phase I/II trial of adjuvant combination chemotherapy with…
JPRN-UMIN000001038 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000001038 |
|---|---|
| Public title | Multicenter phase I/II trial of adjuvant combination chemotherapy with gemcitabine and S-1 for pancreatic cancer |
| Scientific title | Multicenter phase I/II trial of adjuvant combination chemotherapy with gemcitabine and S-1 for pancreatic cancer - Phase I/II trial of adjuvant chemotherapy with gemcitabine and TS-1 for pancreatic cancer |
| Primary sponsor | Study Group for Adjuvant Chemotherapy of Pancreatic Cancer |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase I,II |
| Countries | Japan |
| Conditions | pancreatic cancer |
| Interventions | S1: bid d1-7 q2w x 12 courses PO GEM: d1 q2w x 12 courses DIV The doses of GEM and S-1 in the phase II trial are determined based on the results of the phase I trial. |
| Registration date | Jan 4, 2008 |
| Target size | 55 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: